Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-03

FDA Approved: EXTENDED PHENYTOIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for an Extended Phenytoin Sodium product from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extended Phenytoin Sodium (phenytoin sodium)

Snippet

SUPPL AP for EXTENDED PHENYTOIN SODIUM (PHENYTOIN SODIUM)